Swecure - Chalmers Ventures


Swecure is a biotechnology company developing treatments for immunoregulatory disorders linked to the gut microbiome such as allergy and IBD. Swecure is based on research in bacteriology and immunology from The Sahlgrenska Academy with more than 20 years of experience in the area of infant gut bacterial flora.